Cargando…

Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire

OBJECTIVE: To identify poorly compliant glaucoma patients, using the Eye-Drop Satisfaction Questionnaire (EDSQ). METHODS: This was an observational cross-sectional study with compliance data collected by an electronic monitoring device. Patients with primary open-angle glaucoma or ocular hypertensio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nordmann, Jean-Philippe, Baudouin, Christian, Renard, Jean-Paul, Denis, Philippe, Regnault, Antoine, Berdeaux, Gilles
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009996/ https://www.ncbi.nlm.nih.gov/pubmed/21191445 http://dx.doi.org/10.2147/OPTH.S11818

Ejemplares similares

Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ(©)) in glaucoma using a qualitative study
por: Nordmann, Jean-Philippe, et al.
Publicado: (2007)

Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment
por: Regnault, Antoine, et al.
Publicado: (2010)

Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey
por: Nordmann, Jean-Philippe, et al.
Publicado: (2010)

Vision related quality of life and topical glaucoma treatment side effects
por: Nordmann, Jean-Philippe, et al.
Publicado: (2003)

First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure
por: Denis, Philippe, et al.
Publicado: (2010)

Factors of noncompliance with prescribed eye drops in patients undergoing cataract surgery
por: Nouraeinejad, Ali
Publicado: (2023)

Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database
por: Denis, Philippe, et al.
Publicado: (2008)

Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination
por: Sellem, Eric, et al.
Publicado: (2010)

Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study
por: Theillac, Vincent, et al.
Publicado: (2020)

The Noncompliant Patient
por: Young, James B., et al.
Publicado: (2022)

Assessing the adherence behavior of glaucoma patients to topical eye drops
por: Welge-Lussen, Ulrich, et al.
Publicado: (2014)

Five-year extension of a clinical trial comparing the EX-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma
por: de Jong, Leo, et al.
Publicado: (2011)

The Unhidden Cost of Noncompliance
por: Mahoney, John J., et al.
Publicado: (2008)

Patient satisfaction with glaucoma therapy: reality or myth?
por: Lemij, Hans G, et al.
Publicado: (2015)

Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
por: Gao, Xinbo, et al.
Publicado: (2018)

Anti-inflammatory activity of CKC-containing cationic emulsion eye drop vehicles
por: Daull, Philippe, et al.
Publicado: (2018)

Informative noncompliance in endpoint trials
por: Snapinn, Steven M, et al.
Publicado: (2004)

Treatment compliance and noncompliance in psychoses
por: Rao, K. Nagaraja, et al.
Publicado: (2017)

Eye drop administration in patients attending and not attending a glaucoma education center
por: Al-Busaidi, Aisha, et al.
Publicado: (2016)

Factors affecting eye drop instillation in glaucoma patients with visual field defect
por: Naito, Tomoko, et al.
Publicado: (2017)

Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats
por: Szabo, Edina, et al.
Publicado: (2021)

Patient‐reported reasons for and predictors of noncompliance with compression stockings in a randomized trial of stockings to prevent postthrombotic syndrome
por: Dawson, Andrew J., et al.
Publicado: (2019)

The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
por: Datta, Sandipan, et al.
Publicado: (2017)

Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review
por: Daull, Philippe, et al.
Publicado: (2023)

Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system
por: Li, Jinyang, et al.
Publicado: (2012)

Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2011)

Regulation of Retinal Proteome by Topical Antiglaucomatous Eye Drops in an Inherited Glaucoma Rat Model
por: Schallenberg, Maurice, et al.
Publicado: (2012)

Inter-Rater Agreement in the Assessment of Video Recordings of Eye Drop Instillation by Glaucoma Patients
por: Park, Meghan S., et al.
Publicado: (2016)

Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
por: Junqueira, Daniela M, et al.
Publicado: (2015)

Noncompliance to DOTS: How it can be Decreased
por: Mittal, Chhaya, et al.
Publicado: (2011)

Not Getting to Goal: The Clinical Costs of Noncompliance
por: Ansell, Benjamin J.
Publicado: (2008)

Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017)

Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017)

Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model
por: Pauly, A., et al.
Publicado: (2011)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost–timolol, bimatoprost/bimatoprost–timolol, and travoprost/travoprost–timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
por: Lafuma, Antoine, et al.
Publicado: (2011)

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
por: Economou, Mario A, et al.
Publicado: (2018)

Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
por: Harasymowycz, Paul, et al.
Publicado: (2021)

Efficacy and safety of 1% forskolin eye drops in open angle glaucoma – An open label study
por: Majeed, Muhammed, et al.
Publicado: (2015)

Patients’ Experience of Using Eye Drop Guide Device to Aid Self-Administration of Glaucoma Medications
por: Sakiyalak, Darin, et al.
Publicado: (2020)

Frequency of Use of Fixed-Combination Eye Drops by Patients with Glaucoma at Multiple Private Practices in Japan
por: Inoue, Kenji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gjah09kakbdrn30edrmbv7v5uo